AddLife AB (publ) (ALIF-B) - Net Assets
Based on the latest financial reports, AddLife AB (publ) (ALIF-B) has net assets worth Skr5.66 Billion SEK (≈ $609.54 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Skr13.01 Billion ≈ $1.40 Billion USD) and total liabilities (Skr7.35 Billion ≈ $790.55 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check tangible equity quality of AddLife AB (publ) to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Skr5.66 Billion |
| % of Total Assets | 43.54% |
| Annual Growth Rate | 25.2% |
| 5-Year Change | 26.94% |
| 10-Year Change | 659.8% |
| Growth Volatility | 40.85 |
AddLife AB (publ) - Net Assets Trend (2012–2025)
This chart illustrates how AddLife AB (publ)'s net assets have evolved over time, based on quarterly financial data. See AddLife AB (publ) defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for AddLife AB (publ) (2012–2025)
The table below shows the annual net assets of AddLife AB (publ) from 2012 to 2025. For live valuation and market cap data, see how much is AddLife AB (publ) worth.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | Skr5.45 Billion ≈ $586.18 Million |
+2.60% |
| 2024-12-31 | Skr5.31 Billion ≈ $571.33 Million |
+7.04% |
| 2023-12-31 | Skr4.96 Billion ≈ $533.78 Million |
-0.22% |
| 2022-12-31 | Skr4.97 Billion ≈ $534.96 Million |
+15.85% |
| 2021-12-31 | Skr4.29 Billion ≈ $461.77 Million |
+127.00% |
| 2020-12-31 | Skr1.89 Billion ≈ $203.43 Million |
+28.05% |
| 2019-12-31 | Skr1.48 Billion ≈ $158.86 Million |
+58.44% |
| 2018-12-31 | Skr931.70 Million ≈ $100.27 Million |
+24.56% |
| 2017-12-31 | Skr748.00 Million ≈ $80.50 Million |
+4.34% |
| 2016-12-31 | Skr716.90 Million ≈ $77.15 Million |
+106.84% |
| 2015-12-31 | Skr346.60 Million ≈ $37.30 Million |
+31.64% |
| 2014-12-31 | Skr263.30 Million ≈ $28.34 Million |
-3.06% |
| 2013-12-31 | Skr271.60 Million ≈ $29.23 Million |
-7.40% |
| 2012-12-31 | Skr293.30 Million ≈ $31.56 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to AddLife AB (publ)'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 725.4% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | Skr2.48 Billion | 45.51% |
| Common Stock | Skr62.00 Million | 1.14% |
| Other Components | Skr2.90 Billion | 53.35% |
| Total Equity | Skr5.44 Billion | 100.00% |
AddLife AB (publ) Competitors by Market Cap
The table below lists competitors of AddLife AB (publ) ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Jiangsu Changfa Refrigeration Co Ltd
SHE:002413
|
$2.00 Billion |
|
Hunan Aihua Group Co Ltd
SHG:603989
|
$2.00 Billion |
|
Nyocor Co Ltd
SHG:600821
|
$2.00 Billion |
|
Com7 PCL
BK:COM7
|
$2.00 Billion |
|
Beijing TRS Information Tech
SHE:300229
|
$2.00 Billion |
|
Ningbo Yongxin Optics Co Ltd
SHG:603297
|
$2.00 Billion |
|
Telecom Argentina
BA:TECO2
|
$2.00 Billion |
|
Beijing Highlander Digital Technology Co Ltd
SHE:300065
|
$2.00 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in AddLife AB (publ)'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 5,306,000,000 to 5,443,000,000, a change of 137,000,000 (2.6%).
- Net income of 560,000,000 contributed positively to equity growth.
- Dividend payments of 91,000,000 reduced retained earnings.
- Other comprehensive income decreased equity by 602,000,000.
- Other factors increased equity by 270,000,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Skr560.00 Million | +10.29% |
| Dividends Paid | Skr91.00 Million | -1.67% |
| Other Comprehensive Income | Skr-602.00 Million | -11.06% |
| Other Changes | Skr270.00 Million | +4.96% |
| Total Change | Skr- | 2.58% |
Book Value vs Market Value Analysis
This analysis compares AddLife AB (publ)'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 3.55x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 49.42x to 3.55x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2012-12-31 | Skr3.21 | Skr158.40 | x |
| 2013-12-31 | Skr2.97 | Skr158.40 | x |
| 2014-12-31 | Skr2.88 | Skr158.40 | x |
| 2015-12-31 | Skr4.40 | Skr158.40 | x |
| 2016-12-31 | Skr7.22 | Skr158.40 | x |
| 2017-12-31 | Skr7.31 | Skr158.40 | x |
| 2018-12-31 | Skr9.25 | Skr158.40 | x |
| 2019-12-31 | Skr13.18 | Skr158.40 | x |
| 2020-12-31 | Skr16.71 | Skr158.40 | x |
| 2021-12-31 | Skr35.72 | Skr158.40 | x |
| 2022-12-31 | Skr40.64 | Skr158.40 | x |
| 2023-12-31 | Skr40.69 | Skr158.40 | x |
| 2024-12-31 | Skr43.54 | Skr158.40 | x |
| 2025-12-31 | Skr44.66 | Skr158.40 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently AddLife AB (publ) utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 10.29%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 5.36%
- • Asset Turnover: 0.82x
- • Equity Multiplier: 2.34x
- Recent ROE (10.29%) is below the historical average (17.38%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2012 | 25.25% | 8.14% | 1.49x | 2.08x | Skr44.57 Million |
| 2013 | 28.80% | 7.93% | 1.60x | 2.26x | Skr50.92 Million |
| 2014 | 38.78% | 5.92% | 2.68x | 2.45x | Skr75.70 Million |
| 2015 | 22.45% | 4.98% | 1.22x | 3.68x | Skr43.14 Million |
| 2016 | 15.59% | 5.77% | 1.23x | 2.20x | Skr40.11 Million |
| 2017 | 16.08% | 5.16% | 1.23x | 2.53x | Skr45.50 Million |
| 2018 | 13.89% | 5.21% | 0.93x | 2.87x | Skr36.23 Million |
| 2019 | 9.58% | 4.04% | 1.06x | 2.23x | Skr-6.09 Million |
| 2020 | 27.51% | 9.82% | 1.27x | 2.20x | Skr329.59 Million |
| 2021 | 16.78% | 9.00% | 0.75x | 2.47x | Skr290.48 Million |
| 2022 | 9.66% | 5.28% | 0.70x | 2.63x | Skr-16.80 Million |
| 2023 | 3.83% | 1.96% | 0.76x | 2.57x | Skr-305.80 Million |
| 2024 | 4.75% | 2.45% | 0.79x | 2.46x | Skr-278.60 Million |
| 2025 | 10.29% | 5.36% | 0.82x | 2.34x | Skr15.70 Million |
Industry Comparison
This section compares AddLife AB (publ)'s net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $219,884,118
- Average return on equity (ROE) among peers: -48.21%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| AddLife AB (publ) (ALIF-B) | Skr5.66 Billion | 25.25% | 1.30x | $2.00 Billion |
| ADDvise Group AB A (ADDV-A) | $492.87 Million | 16.45% | 2.99x | $4.23 Million |
| ADDvise Group B (ADDV-B) | $492.87 Million | 16.45% | 2.99x | $108.58 Million |
| Biotage AB (BIOT) | $502.65 Million | 10.17% | 0.23x | $1.23 Billion |
| Bio-Works Technologies AB (BIOWKS) | $22.41 Million | -55.16% | 0.10x | $36.81 Million |
| Bonesupport Holding AB (BONEX) | $124.31 Million | -129.56% | 0.58x | $1.55 Billion |
| Dynavox Group (DYVOX) | $306.20 Million | 34.00% | 4.55x | $797.41 Million |
| iZafe Group AB Series B (IZAFE-B) | $11.69 Million | -61.85% | 0.46x | $17.61 Million |
| Ortivus AB ser. A (ORTI-A) | $17.21 Million | -81.59% | 1.14x | $411.54K |
| Ortivus AB ser. B (ORTI-B) | $8.75 Million | -182.84% | 2.99x | $17.64 Million |
About AddLife AB (publ)
AddLife AB (publ), together with its subsidiaries, provides instruments and equipment, consumables, and reagents primarily to medical care, research, colleges, and universities, as well as the food and pharmaceutical industries. The company operates in two segments, Labtech and Medtech. The Labtech segment offers products, solutions, and services in the areas of diagnostics, and biomedical resear… Read more